Efflux-Mediated Antifungal Drug Resistance
Top Cited Papers
- 1 April 2009
- journal article
- review article
- Published by American Society for Microbiology in Clinical Microbiology Reviews
- Vol. 22 (2) , 291-321
- https://doi.org/10.1128/cmr.00051-08
Abstract
SUMMARY: Fungi cause serious infections in the immunocompromised and debilitated, and the incidence of invasive mycoses has increased significantly over the last 3 decades. Slow diagnosis and the relatively few classes of antifungal drugs result in high attributable mortality for systemic fungal infections. Azole antifungals are commonly used for fungal infections, but azole resistance can be a problem for some patient groups. High-level, clinically significant azole resistance usually involves overexpression of plasma membrane efflux pumps belonging to the ATP-binding cassette (ABC) or the major facilitator superfamily class of transporters. The heterologous expression of efflux pumps in model systems, such Saccharomyces cerevisiae, has enabled the functional analysis of efflux pumps from a variety of fungi. Phylogenetic analysis of the ABC pleiotropic drug resistance family has provided a new view of the evolution of this important class of efflux pumps. There are several ways in which the clinical significance of efflux-mediated antifungal drug resistance can be mitigated. Alternative antifungal drugs, such as the echinocandins, that are not efflux pump substrates provide one option. Potential therapeutic approaches that could overcome azole resistance include targeting efflux pump transcriptional regulators and fungal stress response pathways, blockade of energy supply, and direct inhibition of efflux pumps.Keywords
This publication has 397 references indexed in Scilit:
- Incidence of systemic fungal infection and related mortality following severe burnsBurns, 2008
- Niche-specific gene expression during C. albicans infectionCurrent Opinion in Microbiology, 2008
- Compensatory activation of the multidrug transporters Pdr5p, Snq2p, and Yor1p by Pdr1p in Saccharomyces cerevisiaeFEBS Letters, 2008
- Natural and Synthetic Polymers as Inhibitors of Drug Efflux PumpsPharmaceutical Research, 2007
- Resistance to echinocandin-class antifungal drugsDrug Resistance Updates, 2007
- The yeast Pdr5p multidrug transporter: How does it recognize so many substrates?Biochemical and Biophysical Research Communications, 2007
- Genome evolution in yeastsNature, 2004
- Life with 6000 GenesScience, 1996
- Molecular cloning and characterization of a novel gene of Candida albicans, CDR1, conferring multiple resistance to drugs and antifungalsCurrent Genetics, 1995
- Use of recombinant P-glycoprotein fragments to produce antibodies to the multidrug transporterBiochemical and Biophysical Research Communications, 1990